awmsg logo



ciprofloxacin/dexamethasone (Cilodex®)


Reference No. 1966

Publication date:
22/05/2013


Appraisal information

ciprofloxacin/dexamethasone (Cilodex®) 3 mg/ml/1 mg/ml ear drops


Company: Novartis Pharmaceuticals UK Ltd
BNF category: Ear, nose and oropharynx
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 22/05/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, ciprofloxacin/dexamethasone (Cilodex®) cannot be endorsed for use within NHS Wales for the treatment of the following infections in adults and children: acute otitis media in patients with tympanostomy tubes; acute otitis externa.
Statement of Advice (SOA)
Download